These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16116814)

  • 1. [Foot-and-mouth disease:: an old disease--new solutions].
    Pastoret PP
    Bull Mem Acad R Med Belg; 2005; 160(1-2):103-8; discussion 108. PubMed ID: 16116814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
    Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
    Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
    Bergmann IE; Malirat V; Neitzert E
    Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus.
    Moonen P; van der Linde E; Chénard G; Dekker A
    Vet Microbiol; 2004 Apr; 99(2):93-101. PubMed ID: 15019100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines and companion diagnostic tests for foot-and-mouth disease virus. An overview of the experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2003; 114():59-65. PubMed ID: 14677677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
    Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
    Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous detection of antibodies to foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a multiplexed Luminex assay to differentiate infected from vaccinated cattle.
    Clavijo A; Hole K; Li M; Collignon B
    Vaccine; 2006 Mar; 24(10):1693-704. PubMed ID: 16260073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory considerations for emergency use of vaccines in the European Union.
    Pastoret PP; Mackay D
    Dev Biol (Basel); 2003; 114():53-8. PubMed ID: 14677676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering better vaccines for foot-and-mouth disease.
    Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
    Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination as a control measure during the outbreak of foot-and-mouth disease in 2000 in Korea.
    Park JH; Park JY; Kim YJ; Oem JK; Lee KN; Kye SJ; Joo YS
    Dev Biol (Basel); 2004; 119():63-70. PubMed ID: 15742619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-Mouth disease control using vaccination: the Dutch experience in 2001.
    Pluimers FH
    Dev Biol (Basel); 2004; 119():41-9. PubMed ID: 15742617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
    Niedbalski W
    Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.